A novel method to identify differential pathways in uterine leiomyomata based on network strategy

Area of Science:

• Biochemistry
• Genomics
• Systems Biology

Background:

• Uterine leiomyomata (UL) are common benign tumors with complex molecular underpinnings.
• Identifying differential pathways is crucial for understanding UL pathogenesis and developing targeted therapies.

Purpose of the Study:

• To identify differential pathways in uterine leiomyomata (UL) using a novel network-based approach.
• To explore potential biomarkers for UL detection and treatment.

Main Methods:

• Constructed pathway networks by intersecting Reactome and Search Tool for the Retrieval of Interacting Genes/proteins (STRING) databases.
• Defined an Objective network of differentially expressed genes (DEGs) and their interactions.
• Performed topological centrality analysis to identify hub genes and networks.
• Utilized randomization tests to identify significantly differential pathways.

Main Results:

• Pathway networks comprised 559,598 interactions.
• The Objective network included 657 genes and 3,835 interactions, with 20 identified hub genes.
• 358 pathways interacted with the Objective network, including Signal Transduction, Immune System, and GPCR signaling.
• Randomization tests confirmed these pathways were significantly different in UL (P-values close to 0).

Conclusions:

• Successfully identified differential pathways in UL, including signal transduction, immune system, and GPCR signaling.
• These identified pathways represent potential novel biomarkers for UL diagnosis and therapeutic strategies.
• The network-based methodology provides a robust framework for uncovering disease-specific pathways.